The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications. (Q38542016)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 02 July 2015

Language	Label	Description	Also known as
English	The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.	scientific article published on 02 July 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Maddalena Barba

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rosanna Dattilo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ruggero De Maria

10

object named as

Ruggero De Maria

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

3

object named as

Laura Pizzuti

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Marcella Mottolese

9

object named as

Marcella Mottolese

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Monica Bartucci

8

object named as

Monica Bartucci

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Marcello Maugeri-Saccà

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Luigi Di Lauro

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

2 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Expert Reviews in Molecular Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

e14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The biology of YAP/TAZ: hippo signaling and beyond

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Elucidation of a universal size-control mechanism in Drosophila and mammals

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Hippo pathway and human cancer.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Acidic stress promotes a glioma stem cell phenotype.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Modulating F-actin organization induces organ growth by affecting the Hippo pathway

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Genetic variegation of clonal architecture and propagating cells in leukaemia

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

YAP1 increases organ size and expands undifferentiated progenitor cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Clonal evolution in cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Prospective identification of tumorigenic prostate cancer stem cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Identification of pancreatic cancer stem cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Tumorigenic and metastatic activity of human thyroid cancer stem cells.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Identification and expansion of the tumorigenic lung cancer stem cell population

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Identification and expansion of human colon-cancer-initiating cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Prospective identification of tumorigenic breast cancer cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Physical interaction with Yes-associated protein enhances p73 transcriptional activity

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Comprehensive molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Yes-associated protein (YAP) functions as a tumor suppressor in breast.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

KRAS and YAP1 converge to regulate EMT and tumor survival

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

'Cancer associated fibroblasts'--more than meets the eye.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

TEADs mediate nuclear retention of TAZ to promote oncogenic transformation

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Gene expression profiling in breast cancer: classification, prognostication, and prediction

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

DNA damage repair pathways in cancer stem cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Cancer Stem Cells and Chemosensitivity

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Metabolic control of YAP and TAZ by the mevalonate pathway.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Role of YAP/TAZ in mechanotransduction

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Yes-Associated Protein (YAP) is a critical mediator of c-Jun-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

21 January 2018

Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

The Hippo signaling pathway in stem cell biology and cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct types of tumor-initiating cells form human colon cancer tumors and metastases

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional TargetsCyr61andCTGF

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Metaplastic carcinoma show different expression pattern of YAP compared to triple-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic targeting of cancer stem cells

1 reference

https://api.crossref.org/works/10.1017%2FERM.2015.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/ERM.2015.12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26136233%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38542016&oldid=2115899074"